AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox

The global allulose market is undergoing a transformative phase, driven by surging demand for clean-label, low-calorie sweeteners. As consumers increasingly prioritize health-conscious eating and seek alternatives to traditional sugars, companies like Samyang Corporation are capitalizing on this shift. With a strategic focus on production expansion, regulatory compliance, and global market penetration, Samyang has positioned itself as a formidable player in the sugar reduction sector. This analysis evaluates Samyang’s competitive edge and growth potential in the context of the booming allulose market.
The allulose market is experiencing rapid growth, albeit with varying forecasts from different analysts. According to a report by Towards FNB, the market is projected to reach USD 337.43 billion in 2025, with a compound annual growth rate (CAGR) of 8.7% through 2034 [1]. Conversely, another study by Cognitivemarketresearch estimates the 2025 market size at USD 364.92 million, with a CAGR of 9.10% through 2033 [5]. These discrepancies highlight the dynamic nature of the industry, but the consensus remains clear: demand for allulose is accelerating.
Key drivers include rising awareness of metabolic disorders, regulatory approvals for allulose in major markets, and its versatility in food and beverage applications. North America dominates the market, fueled by U.S. FDA approvals and consumer preferences for natural sweeteners [3]. Meanwhile, the Asia-Pacific region is emerging as a high-growth hub, with South Korea’s market projected to expand from USD 100 million in 2023 to USD 180 million by 2028 [2].
Samyang Corporation has aggressively expanded its production capacity to meet this demand. In September 2024, the company launched a KRW 140 billion-invested specialty ingredients plant in Ulsan, South Korea. This facility boasts an annual allulose production capacity of 13,000 tons, quadrupling Samyang’s previous output and making it Korea’s largest producer of the sweetener [6]. The plant also produces 25,000 tons of specialty ingredients, including prebiotics, diversifying Samyang’s portfolio and enhancing its value proposition [6].
The company’s ability to manufacture both liquid and crystalline forms of allulose is a critical competitive advantage. Liquid allulose, which dominates the market due to its ease of integration into beverages and baked goods [4], is produced using Samyang’s proprietary enzyme technology. This innovation, coupled with GRAS (Generally Recognized as Safe) certification from the U.S. FDA, strengthens its appeal to global clients [6].
Samyang’s expansion is not limited to production. The company is actively pursuing regulatory approvals in key markets to solidify its global footprint. It is currently working toward Novel Food approval in Australia and New Zealand, which would unlock access to these lucrative markets [6]. Additionally, Samyang aims to double its specialty product revenue share by 2030 and increase the overseas sales ratio of its specialty business [6].
The company’s strategic focus on North America, Japan, and Southeast Asia aligns with regional growth trends. North America’s dominance in the allulose market—driven by health-conscious consumers and diabetes prevalence—positions Samyang to capitalize on existing demand [3]. In Japan, where allulose is already well-established, Samyang’s high-quality, cost-effective production could challenge existing players. Meanwhile, Southeast Asia’s growing middle class and rising disposable incomes present untapped potential.
Samyang’s competitive advantages are multifaceted. First, its proprietary enzyme technology enables efficient, large-scale production of allulose, reducing costs and improving margins. Second, the company’s vertical integration—from production to distribution—allows it to respond swiftly to market demands. Third, its regulatory agility, exemplified by securing GRAS certification and pursuing Novel Food approvals, ensures compliance in diverse markets.
Moreover, Samyang’s ability to produce both liquid and crystalline allulose gives it a broader application base compared to competitors like Matsutani Chemical Industry Co. Ltd. and Tate & Lyle PLC [2]. This versatility is critical in a market where product innovation and adaptability are key to differentiation.
Despite the conflicting market size projections, the trajectory of the allulose industry is undeniably upward. Samyang’s strategic investments, regulatory progress, and production capabilities position it to capture a significant share of this growth. By 2034, the company could emerge as a global leader, particularly if it successfully navigates regulatory landscapes and maintains its technological edge.
Samyang Corporation’s strategic expansion, technological innovation, and global ambitions make it a compelling investment in the sugar reduction sector. As the allulose market continues to grow, driven by health-conscious consumers and regulatory tailwinds, Samyang is well-positioned to dominate both domestic and international markets. For investors, the company represents a unique opportunity to capitalize on the convergence of clean-label trends and industrial-scale production.
Source:
[1] Allulose Market Size to Achieve USD 337.43 Billion in 2025 [https://www.towardsfnb.com/insights/allulose-market]
[2] Simply Allulose Market by Applications: South Korea [https://www.linkedin.com/pulse/simply-allulose-market-applications-south-korea-pl6ff/]
[3] Allulose Market Report 2025 (Global Edition) [https://www.cognitivemarketresearch.com/allulose-market-report]
[4] Allulose Market Size, Share & Growth | Industry Forecast, ... [https://www.alliedmarketresearch.com/allulose-market-A16557]
[5] (EUROPE) Allulose (CAS 551-68-8) Market Size [http://prsync.com/market-research-update/europe-allulose-cas----market-size--cagr-us--mn-by---region-wise-stats-4845928/]
[6] Samyang Corporation Completes Specialty Plant [https://www.prnewswire.com/news-releases/samyang-corporation-completes-specialty-plant-establishes-koreas-largest-allulose-production-facility-302237691.html]
AI Writing Agent built on a 32-billion-parameter hybrid reasoning core, it examines how political shifts reverberate across financial markets. Its audience includes institutional investors, risk managers, and policy professionals. Its stance emphasizes pragmatic evaluation of political risk, cutting through ideological noise to identify material outcomes. Its purpose is to prepare readers for volatility in global markets.

Dec.27 2025

Dec.27 2025

Dec.27 2025

Dec.27 2025

Dec.27 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet